CbdMD EBITDA Margin 2017-2024 | YCBD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CbdMD (YCBD) over the last 10 years. The current EBITDA margin for CbdMD as of June 30, 2024 is .
| CbdMD EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-06-30 |
$0.02B |
$-0.00B |
-10.00% |
| 2024-03-31 |
$0.02B |
$-0.00B |
-14.29% |
| 2023-12-31 |
$0.02B |
$-0.00B |
-13.04% |
| 2023-09-30 |
$0.02B |
$-0.01B |
-25.00% |
| 2023-06-30 |
$0.03B |
$-0.01B |
-26.92% |
| 2023-03-31 |
$0.03B |
$-0.01B |
-24.14% |
| 2022-12-31 |
$0.03B |
$-0.01B |
-30.30% |
| 2022-09-30 |
$0.04B |
$-0.01B |
-36.11% |
| 2022-06-30 |
$0.04B |
$-0.02B |
-44.74% |
| 2022-03-31 |
$0.04B |
$-0.02B |
-52.50% |
| 2021-12-31 |
$0.04B |
$-0.02B |
-50.00% |
| 2021-09-30 |
$0.05B |
$-0.02B |
-35.56% |
| 2021-06-30 |
$0.05B |
$-0.01B |
-27.66% |
| 2021-03-31 |
$0.05B |
$-0.01B |
-19.15% |
| 2020-12-31 |
$0.04B |
$-0.01B |
-22.73% |
| 2020-09-30 |
$0.04B |
$-0.02B |
-35.71% |
| 2020-06-30 |
$0.04B |
$-0.02B |
-47.50% |
| 2020-03-31 |
$0.04B |
$-0.02B |
-59.46% |
| 2019-12-31 |
$0.03B |
$-0.02B |
-55.88% |
| 2019-09-30 |
$0.02B |
$-0.01B |
-58.33% |
| 2019-06-30 |
$0.01B |
$-0.01B |
-142.86% |
| 2019-03-31 |
$0.00B |
$-0.01B |
-250.00% |
| 2018-12-31 |
$-0.00B |
$-0.00B |
100.00% |
| 2018-09-30 |
$0.00B |
$-0.00B |
inf% |
| 2018-06-30 |
$0.01B |
$0.00B |
25.00% |
| 2018-03-31 |
$0.01B |
$0.00B |
28.57% |
| 2017-12-31 |
$0.01B |
0 |
0.00% |
| 2017-09-30 |
$0.00B |
$0.00B |
25.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Business Services |
Advertising and Marketing Services |
$0.002B |
$0.024B |
|
cbdMD Inc. owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD. The company's current product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils and CBD pet products. cbdMD Inc., formerly known as Level Brands Inc., is based in Charlotte, United States.
|
